• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Francis Cuss - Articles and news items

Bristol Myers Squibb logo

Bristol-Myers Squibb receives complete Response Letter from U.S. Food and Drug Administration for daclatasvir, an investigational treatment for Hepatitis C

Industry news / 27 November 2014 / Bristol-Myers Squibb

Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for daclatasvir, an NS5A complex inhibitor, in combination with other agents for the treatment of hepatitis C…

Bristol Myers Squibb logo

Bristol-Myers Squibb continues to lead the advancement of immuno-oncology with broad set of new data at 2014 American Society of Clinical Oncology Annual Meeting

Industry news / 6 May 2014 / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer and metastatic renal cell carcinoma will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology…

Bristol Myers Squibb logo

Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement to discover novel immuno-oncology therapies

Industry news / 17 March 2014 / Bristol-Myers Squibb

Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company announced that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies…

Bristol Myers Squibb logo
Bristol Myers Squibb logo

Bristol-Myers Squibb appoints Mike Burgess M.D., Ph.D. Senior Vice President, Discovery Medicine and Clinical Pharmacology

Industry news, News / 17 January 2013 / Bristol-Myers Squibb Company

Bristol-Myers Squibb appoints Mike Burgess…

Bristol Myers Squibb logo

Bristol-Myers Squibb and Tsinghua University enter strategic partnership

Industry news, News / 14 May 2012 / Bristol-Myers Squibb

Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua University’s School of Life Sciences…

Bristol Myers Squibb logo

ASLAN Pharmaceuticals and Bristol-Myers Squibb enter innovative partnership

Industry news, News / 3 November 2011 / Bristol-Myers Squibb Company

Innovative strategic partnership to license and develop investigational oncology compound…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +